Cantor Fitzgerald’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-32,562
Closed -$587K 555
2023
Q2
$587K Buy
+32,562
New +$587K 0.01% 345